{"id":18776,"date":"2025-06-04T10:53:02","date_gmt":"2025-06-04T08:53:02","guid":{"rendered":"https:\/\/adragos-pharma.com\/succes-clinique-dans-le-developpement-de-vaccins-avec-adragos-etude-de-cas\/"},"modified":"2025-07-09T16:32:18","modified_gmt":"2025-07-09T14:32:18","slug":"succes-clinique-vaccins-etude-de-cas-adragos-pharma","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/fr\/succes-clinique-vaccins-etude-de-cas-adragos-pharma\/","title":{"rendered":"Succ\u00e8s clinique vaccins : \u00e9tude de cas Adragos Pharma"},"content":{"rendered":"\n<p>D\u00e9couvrez comment un d\u00e9veloppeur de vaccins bas\u00e9 aux \u00c9tats-Unis a atteint les essais cliniques de phase 3 en seulement 4 ans gr\u00e2ce \u00e0 un partenariat avec Adragos Pharma. Apprenez comment nous pouvons vous aider \u00e0 surmonter les d\u00e9fis complexes de la fabrication en remplissage et finition et acc\u00e9l\u00e9rer votre processus d&rsquo;approbation. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong><strong>Ce que vous d\u00e9couvrirez :<\/strong><\/strong><\/h2>\n\n\n\n<p>Cette \u00e9tude de cas r\u00e9v\u00e8le le parcours pour surmonter des d\u00e9fis complexes de fabrication et d&rsquo;analyse, et fournit des informations exploitables sur la mani\u00e8re de :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>G\u00e9rer plus de 30 ingr\u00e9dients pharmaceutiques actifs (API) uniques avec une tra\u00e7abilit\u00e9 et une conformit\u00e9 totales.<\/li>\n\n\n\n<li>Mettre en \u0153uvre une documentation personnalis\u00e9e et un traitement aseptique rigoureux.<\/li>\n\n\n\n<li>\u00c9tablir des protocoles analytiques align\u00e9s sur les normes USP et EP.<\/li>\n\n\n\n<li>Atteindre une efficacit\u00e9 de production maximale tout en maintenant une qualit\u00e9 sans compromis.<\/li>\n<\/ul>\n\n\n\n<p>D\u00e9couvrez comment notre flexibilit\u00e9 dans la planification, notre formation d\u00e9di\u00e9e des op\u00e9rateurs et notre optimisation continue des processus ont permis une progression rapide \u00e0 travers les phases cliniques, soutenant ainsi l&rsquo;innovation et la s\u00e9curit\u00e9 dans le d\u00e9veloppement de vaccins.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Pr\u00eat \u00e0 en savoir plus ?<\/strong> <\/h2>\n\n\n\n<p>T\u00e9l\u00e9chargez d\u00e8s maintenant l&rsquo;\u00e9tude de cas compl\u00e8te et obtenez des informations exploitables pour stimuler votre prochain succ\u00e8s en fabrication clinique.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/share-eu1.hsforms.com\/1JVfQxVA4Qtiho6K8b-czpwfxkpu\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"1024\" height=\"535\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/06\/case-study-1-1-1024x535.png\" alt=\"\" class=\"wp-image-18214\" srcset=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/06\/case-study-1-1-1024x535.png 1024w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/06\/case-study-1-1-300x157.png 300w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/06\/case-study-1-1-768x401.png 768w, https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/06\/case-study-1-1.png 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00e9couvrez comment un d\u00e9veloppeur de vaccins bas\u00e9 aux \u00c9tats-Unis a atteint les essais cliniques de phase 3 en seulement 4 ans gr\u00e2ce \u00e0 un partenariat avec Adragos Pharma. Apprenez comment nous pouvons vous aider \u00e0 surmonter les d\u00e9fis complexes de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[246],"tags":[303,304,306,305],"topics":[293,287,285],"locations":[274],"experts":[299],"class_list":["post-18776","post","type-post","status-publish","format-standard","hentry","category-ressources","tag-cdmo-fr","tag-developpement-de-vaccins","tag-flacons-en-verre","tag-remplissage-et-finition","topics-biologics","topics-clinical-manufacturing","topics-fill-and-finish","locations-jura","experts-marie-sophie-quittet"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/18776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/comments?post=18776"}],"version-history":[{"count":2,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/18776\/revisions"}],"predecessor-version":[{"id":20104,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/posts\/18776\/revisions\/20104"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=18776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/categories?post=18776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/tags?post=18776"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/topics?post=18776"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/locations?post=18776"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/fr\/wp-json\/wp\/v2\/experts?post=18776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}